Ironwood Pharmaceuticals | IRWD - 税前利润

股票价格
3.04
每天变化
-0.19 -5.88%
每月一次
-18.93%
每年
115.60%
Q1 预测
2.95


金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 505.6M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


税前利润 更改 日
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Almirall EUR 30.32M 22M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amarin USD -852K 7.26M 2025-12
Ardelyx USD -400K 467K 2025-12
Astellas Pharma JPY 133.96B 29.77B 2025-12
AstraZeneca USD 3.24B 117M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Coherus Biosciences USD -46.35M 90.86M 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Exact Sciences USD -17.76M 17.7M 2025-09
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Incyte USD 389.94M 92.37M 2025-12
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
MacroGenics USD -14.93M 31.75M 2025-12
Moderna USD -187M 631M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Pacira USD 9.52M 11.45M 2025-09
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Takeda JPY 133.86B 105.69B 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12